Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00066326
Status:
COMPLETED
Last Update Posted:
2013-04-05
First Post:
2003-08-06
Brief Title:
Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Barbara Ann Karmanos Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |